4.6 Article

HACE1: A Novel Repressor of RAR Transcriptional Activity

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 107, Issue 3, Pages 482-493

Publisher

WILEY
DOI: 10.1002/jcb.22146

Keywords

RETINOIC ACID; RAR; HACE1; TRANSCRIPTION; AF-1

Funding

  1. National Institutes of Health [DK67558, DK44517, CA64945]
  2. NATIONAL CANCER INSTITUTE [R01CA064945] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067558, R01DK044517] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The diverse biological actions of retinoic acid (RA) are mediated by RA receptors (RARs) and retinoid X receptors (RXRs). While the coregulatory proteins that interact with the ligand-dependent AF-2 in the E region are well studied, the ligand-independent N-terminal AF-1 domain-interacting partners and their influence(s) on the function of RARs are poorly understood. HECT domain and Ankyrin repeat containing E3 ubiquitin-protein ligase (HACE1) was isolated as a RAR beta(3) AB region interacting protein. HACE1 interacts with RAR beta(3) both in in vitro GST pull-down and in cell-based coprecipitation assays. The interaction sites map to the N terminus of RAR beta(3) and the C terminus of HACE1. HACE1 functionally represses the transcriptional activity of RAR alpha 1, RAR beta isoforms 1, 2, and 3, but not RAR gamma(1) in luciferase reporter assays. In addition, HACE1 represses the endogenous PAR-regulated genes CRABP II, RIG1 and RAR beta(2), but not RAI3 in CAOV3 cells. Mutation of the putative catalytic cysteine (C876 of LF HACE1), which is indispensable for its E3 ubiquitin ligase activity, does not alter the repressive effect of HACE1 on the transcriptional activity of RAR beta(3). On the other hand, HACE1 inhibits the RA dependent degradation of RAR beta(3). It is possible that the repression of RAR-regulated transcription by HACE1 is due to its ability to inhibit the RA-dependent degradation of RARs. J. Cell. Biochem. 107: 482-493, 2009. (C) 2009 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available